|
|
|
Life Sciences Technology Practice Group -
Biotechnology & Pharmaceuticals Sector |
|
The collaboration of these two markets is continuing. Drug discovery, and its
eventual development into viable therapeutics, is the goal of most early stage
firms, as well as, large pharmaceutical companies. Leveraging business
development relationships with large pharmaceutical companies can only enhance
such goals and provide the patients with appropriate therapeutics in a timely
manner at improving costs.
Companies that can provide the drug discovery tools and services necessary to
improve the discovery and development process will be important to this
continuum of product development. The consumer will benefit with improved
technologies, as it will speed the time to market. Finding the talent to
address the regulatory, operational and commercial aspects of this industry is
our expertise.
Practice Leader:
John Baker
- Boston
Michael Burroughs
- St. Louis
Michael Carey
- New York
Caroline Edwards
- Hong Kong (Headquarters, Asia Pacific)
Matthew Faber
- Stamford
Dr. Chris Goward
- London (Headquarters, Europe)
Joel Grushkin
- San Diego
Gary Hegenbart
- Irvine
Mark James
- San Diego
Julie Kanak
- Chicago (Global Headquarters)
John McLean
- Chicago (Global Headquarters)
Larry Munson
- St. Louis
Mike Nagata
- Tokyo
Mercedes Paz
- Los Angeles
Bart Penfold
- San Francisco
Donald Pizzi
- Newark
Lawrence Poster
- New York
Scott Rabinowitz
- Seattle
Craig Randall
- Chicago (Global Headquarters)
Shigemasa Saida
- Tokyo
Arthur Sandler
- San Francisco
KC Sim
- Shanghai
Kimberly Vaughn
- Atlanta
Lauren Lee White
- Newark
Lance Winn
- Austin
|
|
|
